Stephen Hawser

Stephen Hawser is the Chief Executive Officer (CEO) of IHMA Europe Sàrl, a subsidiary of International Health Management Associates, Inc. (IHMA) based in Monthey, Switzerland.12 With over 30 years of experience in the anti-infective industry, Hawser has been leading IHMA Europe Sàrl since 2009.5

Professional Background

Stephen Hawser holds a PhD and has extensive expertise in antimicrobial drug development and resistance.4 His career has been focused on addressing the challenges in the pharmaceutical industry, particularly in the field of antimicrobial agents.

Role at IHMA

As CEO of IHMA Europe Sàrl, Hawser oversees a company that specializes in:

1. Antimicrobial drug development studies
2. Surveillance studies and clinical trials
3. Supporting drug discovery, clinical development, regulatory approval, and commercialization of antimicrobial agents1

Under his leadership, IHMA has become a premier provider of services to biotechnology, pharmaceutical, and diagnostic industries worldwide.1

Achievements and Contributions

Hawser's expertise has contributed to IHMA's significant accomplishments:

• Supporting the discovery, development, and launch of hundreds of antimicrobial agents
• Establishing relationships with over 1,500 healthcare institutions across more than 80 countries
• Building a repository of hundreds of thousands of clinically relevant bacterial isolates
• Contributing to over 1,000 scientific presentations and publications1

Stephen Hawser's LinkedIn profile (username: stephen-hawser-b3903960) reflects his role as CEO at IHMA Europe Sàrl and his extensive experience in the pharmaceutical industry.3